OTCM
IGNE
Market cap15kUSD
Nov 03, Last price
0.00USD
Name
Igene Biotechnology Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Key people
Vice Chairman of the Board
Edward Weisberger
Chief Financial Officer · since 2001
Patrick Monahan
Vice President, Secretary, Director of Manufacturing, Director · since 2002
Stephen Hiu
President, Chief Technical Officer, Treasurer, Director of R&D, Director · since 2002
Michael Kimelman
Chairman of the Board · since 1991
Director · since 1982
Valuation
No data to show